Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Satellite Bio has raised $82.5M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Satellite Bio's investors include Lightspeed Venture Partners, Alumni Ventures, Catalio Capital Management, Polaris Partners, S32.
Satellite Bio is headquartered in Newton, United States.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Satellite Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Satellite Bio — Funding & Investors." VCBacked, March 7, 2022, https://www.vcbacked.co/company/satellite-bio. Accessed September 29, 2026.
VCBacked. (2022). Satellite Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/satellite-bio
{{cite web |title=Satellite Bio — Funding & Investors |url=https://www.vcbacked.co/company/satellite-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated